MKLN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.284800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.763000E-01
Normal-vs-Stage2
6.940200E-01
Normal-vs-Stage3
2.719500E-02
Normal-vs-Stage4
8.105200E-01
Stage1-vs-Stage2
9.958200E-01
Stage1-vs-Stage3
1.567730E-02
Stage1-vs-Stage4
6.234600E-01
Stage2-vs-Stage3
6.526000E-02
Stage2-vs-Stage4
6.146000E-01
Stage3-vs-Stage4
2.180000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.823000E-01
Normal-vs-AfricanAmerican
6.000000E-01
Normal-vs-Asian
5.232400E-01
Caucasian-vs-AfricanAmerican
5.833600E-02
Caucasian-vs-Asian
5.173400E-01
AfricanAmerican-vs-Asian
1.609420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.540800E-01
Normal-vs-Female
6.117800E-01
Male-vs-Female
8.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.812600E-01
Normal-vs-Age(41-60Yrs)
8.606800E-01
Normal-vs-Age(61-80Yrs)
4.494800E-01
Normal-vs-Age(81-100Yrs)
2.259000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.641200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.791200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.295400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.175200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.665900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.348400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.160200E-01
Normal-vs-Daily Drinker
3.002800E-01
Normal-vs-Weekly Drinker
6.519200E-01
Normal-vs-Occasional Drinker
6.052000E-01
Normal-vs-Social Drinker
9.318600E-01
Non Drinker-vs-Daily Drinker
7.457400E-01
Non Drinker-vs-Weekly Drinker
7.607400E-01
Non Drinker-vs-Occasional Drinker
3.709800E-01
Non Drinker-vs-Social Drinker
1.634180E-01
Daily Drinker-vs-Weekly Drinker
5.976200E-01
Daily Drinker-vs-Occasional Drinker
2.160400E-01
Daily Drinker-vs-Social Drinker
9.334300E-02
Weekly Drinker-vs-Occasional Drinker
7.418800E-01
Weekly Drinker-vs-Social Drinker
4.523200E-01
Occasional Drinker-vs-Social Drinker
5.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.856050E-01
Normal-vs-Grade 2
3.769800E-02
Normal-vs-Grade 3
5.812100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.007900E-02
Grade 1-vs-Grade 3
1.087800E-01
Grade 1-vs-Grade 4
1.856050E-01
Grade 2-vs-Grade 3
8.361200E-01
Grade 2-vs-Grade 4
3.769800E-02
Grade 3-vs-Grade 4
5.812100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.510600E-01
Normal-vs-NonDiabetic
4.923000E-01
Diabetic-vs-NonDiabetic
9.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.002600E-01
Normal-vs-NoPancreatitis
5.011400E-01
Pancreatitis-vs-NoPancreatitis
3.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.127400E-01
Normal-vs-N1
7.065000E-01
N0-vs-N1
3.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.302200E-01
Normal-vs-TP53-NonMutant
7.845000E-01
TP53-Mutant-vs-TP53-NonMutant
4.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
